Regeneron Pharmaceuticals (REGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | REGN | AMGN | VRTX | BMY | GILD |
| Company | Regeneron Pharmaceuticals | Amgen Inc | Vertex Pharmaceutic | Bristol-Myers Squibb Company | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NYSE | NASDAQ |
| Open | 900.00 | 277.69 | 402.95 | 44.36 | 65.75 |
| High | 921.51 | 278.52 | 403.92 | 44.42 | 65.80 |
| Low | 891.30 | 275.79 | 399.37 | 43.37 | 64.89 |
| Last | 906.31 | 275.73 | 399.09 | 43.68 | 65.32 |
| Change | +2.83 | -1.64 | -3.05 | -0.53 | -0.19 |
| % Change | +0.31% | -0.59% | -0.76% | -1.20% | -0.29% |
| Volume | 117,563 | 192,751 | 86,101 | 1,988,588 | 534,874 |
| 20-Day Average Volume | 457,906 | 2,122,096 | 955,225 | 13,552,366 | 7,080,954 |
| Previous Close | 903.48 | 277.37 | 402.14 | 44.21 | 65.51 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 907.59 | 270.09 | 398.69 | 47.82 | 67.10 |
| 20-Day Raw Stochastic | 41.56% | 81.05% | 46.30% | 0.43% | 6.88% |
| 20-Day Relative Strength | 43.77% | 51.62% | 46.08% | 27.02% | 30.75% |
| Weighted Alpha | +17.65 | +13.90 | +13.84 | -37.63 | -22.28 |
| Today's Opinion | 8% Buy | 24% Sell | 8% Buy | 88% Sell | 100% Sell |
| Previous Opinion | 8% Buy | 24% Sell | 8% Buy | 88% Sell | 100% Sell |
| Last Month's Opinion | 56% Buy | 8% Sell | 40% Buy | 8% Sell | 100% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.75% since 04/25/24 | +2.54% since 04/25/24 | +0.52% since 04/25/24 | -2.66% since 04/25/24 | -0.41% since 04/25/24 |
| Low | 875.22 on 04/26/24 | 265.72 on 04/26/24 | 391.70 on 04/30/24 | 43.47 on 05/02/24 | 64.63 on 04/26/24 |
| High | 921.51 on 05/02/24 | 279.84 on 05/01/24 | 406.95 on 05/01/24 | 45.38 on 04/29/24 | 66.91 on 04/29/24 |
| 1-Month | |||||
| %Chg | -5.08% since 04/02/24 | unch since 04/02/24 | -2.36% since 04/02/24 | -17.50% since 04/02/24 | -9.83% since 04/02/24 |
| Low | 875.22 on 04/26/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 43.47 on 05/02/24 | 64.63 on 04/26/24 |
| High | 962.20 on 04/04/24 | 279.84 on 05/01/24 | 414.95 on 04/03/24 | 52.87 on 04/03/24 | 72.17 on 04/03/24 |
| 3-Month | |||||
| %Chg | -4.12% since 02/02/24 | -14.54% since 02/02/24 | -5.87% since 02/02/24 | -10.68% since 02/02/24 | -15.54% since 02/02/24 |
| Low | 875.22 on 04/26/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 43.47 on 05/02/24 | 64.63 on 04/26/24 |
| High | 998.33 on 02/28/24 | 329.72 on 02/05/24 | 437.00 on 02/27/24 | 55.03 on 03/13/24 | 77.87 on 02/06/24 |
| 6-Month | |||||
| %Chg | +10.68% since 11/02/23 | +3.61% since 11/02/23 | +6.17% since 11/02/23 | -14.90% since 11/02/23 | -19.98% since 11/02/23 |
| Low | 783.57 on 11/10/23 | 260.52 on 11/21/23 | 341.90 on 11/16/23 | 43.47 on 05/02/24 | 64.63 on 04/26/24 |
| High | 998.33 on 02/28/24 | 329.72 on 02/05/24 | 448.40 on 01/30/24 | 55.03 on 03/13/24 | 87.86 on 01/19/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 99,167,768 | 148,774,592 | 103,936,712 | 89,618,088 | 81,565,000 |
| Shares Outstanding, K | 109,762 | 536,376 | 258,459 | 2,027,100 | 1,245,077 |
| Annual Sales | 13,117,200,000 | 28,190,000,000 | 9,869,200,000 | 45,006,000,000 | 27,116,000,000 |
| Annual Net Income | 3,953,600,000 | 6,717,000,000 | 3,619,600,000 | 8,025,000,000 | 5,665,000,000 |
| Last Quarter Sales | 3,434,300,000 | 8,196,000,000 | 2,517,700,000 | 11,865,000,000 | 6,686,000,000 |
| Last Quarter Net Income | 1,159,600,000 | 767,000,000 | 968,800,000 | -11,911,000,000 | -4,170,000,000 |
| 60-Month Beta | 0.17 | 0.60 | 0.39 | 0.45 | 0.22 |
| Per-Share Information | |||||
| Most Recent Earnings | 11.86 on 02/02/24 | 4.71 on 02/06/24 | 4.20 on 02/05/24 | -4.40 on 04/25/24 | -1.32 on 04/25/24 |
| Latest Earnings Date | 05/02/24 | 05/02/24 | 05/06/24 | 04/25/24 | 04/25/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | N/A | 0.600 on 04/04/24 | 0.770 on 03/14/24 |
| Next Ex-Dividends Date | N/A | 05/16/24 | N/A | 04/04/24 | 06/14/24 |
| Ratios | |||||
| Price/Earnings ttm | 23.70 | 14.69 | 29.23 | 41.85 | 16.18 |